{"id":"https://openalex.org/A5114094907","orcid":null,"observed_orcids":[],"display_name":"Ruey Pham","raw_author_names":["Ruey Pham"],"full_name":"Ruey Pham","works_count":1,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5114094907","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210114883","ror":"https://ror.org/01gbymr57","display_name":"Tempus Labs (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114883"]},"years":[2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210114883","ror":"https://ror.org/01gbymr57","display_name":"Tempus Labs (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114883"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","value":1.27e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":2.2e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","value":2.2e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","score":0.6882949471473694},{"id":"188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","score":0.5036796927452087},{"id":"147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","score":0.3633190393447876},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.3472251296043396},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.3297560513019562}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":1}],"display_name_alternatives":["Ruey Pham"],"block_key":"r pham","works_api_url":"https://api.openalex.org/works?filter=author.id:A5114094907","awards_count":0,"updated_date":"2026-11-02T12:28:04","created_date":"2023-11-01T00:00:00"}